Macronutrients in Lactating NICU Parents - Impact of Kangaroo Care
Launched by UNIVERSITY OF CALIFORNIA, DAVIS · Sep 14, 2023
Trial Information
Current as of July 01, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial, called "Macronutrients in Lactating NICU Parents - Impact of Kangaroo Care," is exploring how Kangaroo Care—holding your baby skin-to-skin on your chest—affects breastfeeding for parents with infants in the Neonatal Intensive Care Unit (NICU). The goal is to understand if this practice helps parents produce more milk, especially for babies who can't breastfeed directly due to being premature or having other health issues.
To participate, you need to be a lactating parent of a baby in the UCDMC NICU who is at least 1 week old and expected to stay in the NICU for at least two weeks. You should also be willing to express milk using a hospital-grade pump and visit the hospital for four appointments within ten days. If you're interested, this study could provide valuable insights into supporting breastfeeding for NICU parents while helping you bond with your baby through Kangaroo Care.
Gender
FEMALE
Eligibility criteria
- Inclusion Criteria:
- Lactating Parent/Infant Dyads:
- • 1. Lactating parents of infants who are currently admitted to the UCDMC NICU and are expected to remain in the NICU for at least 2 weeks from study enrollment
- • 2. Lactating parent is 18 years of age or older
- • 3. Infant with prematurity or other conditions prohibiting nutritive feeding at the breast during the study period
- • 4. Lactating parent plans to feed their infants breast milk for at least 1 month
- • 5. Lactating parent is willing to refrain from tandem feeding another child during the study period
- • 6. Willing to refrain from enrolling infant in an interventional research study that may impact growth or feeding tolerance during the study period
- • 7. Lactating parent is willing to use a hospital grade pump available in the NICU to express milk for sample collection
- • 8. Lactating Parent that is willing to travel to UCDMC on 4 occasions within a 10 day period for study visits
- Providers/staff:
- • 1. Physicians, nurses, fellows, residents, and NICU staff involved in the implementation of Kangaroo care for the MILK study.
- Exclusion Criteria:
- • 1. Infant less than 1 week of age at enrollment
- • 2. Lactating parents expressing breast milk for more than one infant
- • 3. Lactating parents who are currently or plan to tandem feed another child during the study period
- • 4. Lactating parents that are participating in an interventional research study that could influence breast milk production.
- • 5. Lactating parents with infants deemed by primary investigator/primary care team to be too unstable for kangaroo care
- • 6. Lactating parents that are unwilling to participate in kangaroo care
- • 7. Dyads that have participated in nutritive feeding at the breast
- • 8. Lactating parents that use recreational drugs that contraindicate breastfeeding/provision of breast milk
- • 9. Lactating parents taking therapies, supplements, or medications that are incompatible with breastfeeding/provision of breast milk to their infant
- • 10. Lactating parents using, or planning to use, any over-the-counter or prescription medication for the purpose of increasing milk supply (including domperidone, fenugreek, turmeric, blessed milk thistle, Brewer's yeast, or lactation cookies)
- • 11. Lactating parents that are involuntarily confined
- • 12. Lactating parents that are adults unable to consent
- • 13. Lactating parents unwilling to travel to UC Davis NICU for study visits
- • 14. Anyone deemed unfit for participation by the investigator(s)
About University Of California, Davis
The University of California, Davis (UC Davis) is a leading research institution renowned for its commitment to advancing healthcare through innovative clinical trials and studies. With a strong focus on interdisciplinary collaboration, UC Davis leverages its extensive expertise in medical research, education, and patient care to drive breakthroughs in various fields, including medicine, public health, and agriculture. The university's clinical trial programs emphasize rigorous scientific methodology and ethical standards, aiming to translate research findings into impactful treatments and improved patient outcomes. Through its state-of-the-art facilities and a dedicated team of researchers and healthcare professionals, UC Davis is at the forefront of transforming healthcare practices and addressing critical health challenges.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Sacramento, California, United States
Patients applied
Trial Officials
Kara Kuhn-Riordon, MD
Principal Investigator
UC Davis
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported